Trials / Terminated
TerminatedNCT00924417
A Distraction Protocol for Peripheral Intravenous (IV) Placement in the Pediatric Emergency Department
A Distraction Protocol for Peripheral IV Placement in the Pediatric Emergency Department
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
- Sex
- All
- Age
- 4 Years – 9 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, controlled trial of a distraction protocol for peripheral intravenous line placement in the pediatric emergency department. Patients and parents will be randomized to one of two interventions: routine care or a teaching session about the cognitive technique known as distraction. The study seeks to enroll children ages 4-9, who are cognitively normal, who are without significant chronic medical illness, who are receiving intravenous line placement as part of routine care in the pediatric emergency department. Study investigators hypothesize that patients in the intervention group will report less pain than patients in the control group.
Detailed description
Routine care patients will have intravenous lines placed in the usual manner. Intervention patient families will have a teaching session about distraction techniques, and distraction will be used during the intravenous line placement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Routine Care | Parent given placebo intervention that entails brief information about what is routine care for intravenous line placement in the emergency department |
| BEHAVIORAL | Distraction | Parent given brief information about the cognitive behavioral technique known as distraction. Parent and child then given 3 distraction "toys/tools" to assist with peripheral intravenous line placement. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-06-19
- Last updated
- 2018-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00924417. Inclusion in this directory is not an endorsement.